Hyperphosphatemia clinical trials

Explore recruiting hyperphosphatemia clinical trials.

Recruiting hyperphosphatemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hyperphosphatemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Prospective, Open-Label, Phase IIb/III Study to Evaluate the Risk of TLS and Optimization of the Initiation of Venetoclax in Combination with Obinutuzumab or Acalabrutinib With Different Ramp-Up Periods in Previously Untreated Subjects with CLL

France, Greece, Spain

Phase II and Phase III (Integrated) EU CTIS Study details

Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascending Dose Portion and a Phase 2 Open-Label Portion, to Evaluate the Safety and Efficacy of Oral Infigratinib in Infants and Young Children with Achondroplasia

Spain, Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Hyperphosphatemia trials by city

Hyperphosphatemia in Toronto Hyperphosphatemia in Vancouver Hyperphosphatemia in Montreal Hyperphosphatemia in Calgary Hyperphosphatemia in Edmonton Hyperphosphatemia in Ottawa Hyperphosphatemia in Winnipeg Hyperphosphatemia in Quebec City Hyperphosphatemia in Hamilton Hyperphosphatemia in Kitchener Hyperphosphatemia in London Hyperphosphatemia in Halifax Hyperphosphatemia in New York Hyperphosphatemia in Los Angeles Hyperphosphatemia in Chicago Hyperphosphatemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease